Dave Tudor

Dave is the Managing Director of the Medicines Manufacturing Innovation Centre, Quality and Biologics. The Medicines Manufacturing Innovation Centre is a collaboration between CPI, University of Strathclyde, UKRI, Scottish Enterprise and founding industry partners, AstraZeneca and GSK. The centre will ensure the UK is a technology and innovation leader in pharmaceutical manufacturing, thereby boosting the competitiveness of both sectors. The initial focus will be on technology translation for small molecule drug manufacture. Dave also leads the Biologics business unit, CPI’s Quality function, which includes GMP obligations and CPI's PMO function.